On April 17, 2017, Meishen’s marketing director and the minister of international trade took off for Japan, and attended the CPhI Japan 2017.
The exhibition time of CPhI Japan 2017 is from April 17 to 21. This exhibition held every year term since 2002. It is one of the acridine series of exhibitions around the world, and the biggest international medicine raw material exhibition in Japan. The Japan is the world’s second largest medicine raw material market, and occupies 15 percent of prescription medicine market capitalisation in the world. It provides opportunities to Meishen Technology. Therefore, the pharmaceutical grade magnesium oxide, magnesium carbonate and magnesium sulfate of Meishen can further expand Asia market. It exploits the export of Meishen’s medicine material, and increases chances to enter international market.
Hebei Meishen Technology Co., Ltd is the largest manufacturer to produce pharmaceutical grade magnesium oxide, magnesium carbonate and magnesium sulfate. It is a modern new high-tech enterprise close interactions with industry, university and research. Depends on the research and development technology of Tsinghua University and Hebei University of Science and Technology, Meishen develops to a industry-university-research body, and has independent property rights and complete industrial chain.
Trough this CPhI, Meishen listens to the customer requirements, buyers’ professional views for pharma grade magnesium oxide, pharma grade magnesium carbonate and pharma grade magnesium sulfate, gets to know a lot of customers and accumulates customer base. It lays a root for a better marketing in the future. We believe that, after the vigorously promoting and following up, Meishen brand can across our country and go to the world.